SUDEEPPHRM Hits 52-Week High, Up 2.75%: Inside the Momentum Story Moving Sudeep Pharma Shares

Why SUDEEPPHRM is being traded today

The momentum story around Sudeep Pharma (SUDEEPPHRM) has the stock at ₹1,329.30, +2.75% on the session, with the NSE board read at 12:05 am IST on 5 September 2026. What the tape shows: the stock is printing at the top of its own twelve-month range — there is no overhead supply from earlier buyers left above this level, which is why breakouts here extend when volume follows.

What you need to know

• Where it trades: Sudeep Pharma is at ₹1,329.30, +36.50 (+2.75%) versus the previous close of ₹1,329.30.
• Why it is moving: a momentum story — one business desk filed on the company in the last few hours.
• Today's band: ₹1,300.00 to ₹1,357.40, against an open of ₹1,300.10 — the stock is defending its opening print.
• Twelve-month context: -2.59% below the ₹1,296 high and 153.66% above the ₹524 low, so the stock sits in the upper part of its own range.
• Participation: turnover is running at 0.8x the twenty-day average, which is ordinary flow — the move lacks a volume endorsement so far.
• What to watch: whether the next earnings print supports the multiple the stock has moved to, because momentum unwinds fastest where it does not.

The momentum angle

The reason Sudeep Pharma is on the desks today is a momentum story — reported by one desk so far, with the headlines linked below. Momentum coverage follows price rather than leading it, so the question it raises is whether earnings are keeping pace with the re-rating or the multiple is doing all the work.

Where the price stands right now

Who is reporting what

Headlines are listed for context and link straight to the publisher. The prices, ranges and tables on this page are read independently from exchange data at the timestamp shown.

• Sudeep Pharma among 8 commodities stocks hitting 52-week highs; rallied up to 55% in a month — Economic Times

When a re-rating stops being about earnings

A stock can rise for two reasons: because it earns more, or because the market pays more for the same earnings. The first is durable, the second is conditional. Momentum coverage almost always follows price rather than leading it, so the useful question when a name starts appearing on best-performer lists is which of the two has done the work.

The test is simple in principle: compare the price rise over the period with the growth in earnings over the same period. Where price has run far ahead, the multiple is carrying the move and the next earnings print has to justify it. Where earnings have kept pace, the re-rating has a floor under it.

Sudeep Pharma at ₹1,329.30 is -2.59% below its twelve-month high of ₹1,296, which is the reference point momentum screens use.

Trailing returns in context

What the returns table is saying

Over the last week Sudeep Pharma has gained +17.21% and over the month +38.62%. Both horizons pointing the same way means the recent move is an extension of the existing trend rather than a reversal.

The twelve-month return of +71.71% is the context long-term holders judge the stock on. After a run of this size, most of the easy re-rating is behind the price, so incremental gains usually have to come from delivered earnings rather than sentiment.

Reading the price against its own ranges

Over the last twelve months the price has covered ₹524 to ₹1,296. The current level is 104% of the way through that band, -2.59% below the 52-week high and 153.66% above the 52-week low. Trading this close to the yearly high means there is little overhead supply from earlier buyers, which is why breakouts here tend to extend — but it also leaves no cushion if the news flow turns.

Traded quantity of 2,42,835 shares is 0.79x the 20-day average of 3,06,147. Turnover close to the recent norm suggests an orderly session rather than a scramble, so the move reflects ordinary two-way flow.

Price action, level by level

Sudeep Pharma has traded between ₹1,300.00 and ₹1,357.40 in this session against an open of ₹1,300.10 and a previous close of ₹1,329.30. That is a band of ₹57.40, or 4.32% of the current price — a wide day, which means intraday positions are being forced rather than chosen.

Holding above the open at ₹1,300.10 matters because it is the level intraday desks use as the session pivot: buyers who entered at the open are in profit, so there is no forced supply from that cohort.

In market-structure terms this is a continuation session, so the prior trend remains the base case until a level breaks.

The follow-up checklist

For this momentum story specifically, watch whether the next earnings print supports the multiple the stock has moved to, because momentum unwinds fastest where it does not. On the chart, the ₹1,357.40 high and ₹1,300.00 low of this session are the reference levels — a higher low in the next session turns a headline reaction into a trend, a break of today's low usually voids it. Participation is the third check: the move needs turnover at or above the stock's own 20-day average of 3,06,147 shares to be read as positioning rather than a squeeze.

What this means for investors

For a trader, the setup is a range breakout: the reference is today's ₹1,357.40 high, and a close above it with volume keeps the trend intact. The invalidation is equally clean — a slip back under ₹1,300.00 puts the stock back inside the range it just left, and breakouts that fail tend to retrace to the middle of that range.

For a long-term shareholder, one session tells you very little. The stock is -2.59% off its twelve-month high, so the more useful exercise is comparing that drawdown with the change in earnings over the same period: price falling faster than profits is an opportunity, the reverse is a warning.

On risk: this report is a reading of live exchange data at a point in time, and intraday levels change. Position sizing — not conviction about the story — is what determines the outcome of a trade built on a headline, and averaging into a falling price without a change in the underlying facts is how a trade becomes an unintended long-term holding.

The bottom line

Sudeep Pharma is being bought on a momentum story, and at ₹1,329.30 the move is not yet backed by turnover above its own average, which is the version of a rally that tends to fade. The day's ₹1,300.00–₹1,357.40 band is the frame for the next session, and whether the next earnings print supports the multiple the stock has moved to is what resolves the story either way.

Where to track SUDEEPPHRM next

Live price, charts and technicals stay on the Sudeep Pharma stock page, and every filed quarter is tabulated on its quarterly results page. Both pages refresh from the exchange feed through the session, so they carry a later reading than this report once the market has moved on.

Frequently asked questions

What is the Sudeep Pharma share price today?

Sudeep Pharma (SUDEEPPHRM) last traded at ₹1,329.30, +36.50 (+2.75%) against the previous close of ₹1,329.30, read from the NSE board at 12:05 am IST on 5 September 2026.

Why is Sudeep Pharma in the news today?

1 business publisher ran headlines on the company in the last session — a momentum story. Their reports are linked above; the levels and tables here are read independently from exchange data.

What is the 52-week high and low of SUDEEPPHRM?

Over the last twelve months SUDEEPPHRM has traded between a low of ₹524 and a high of ₹1,296, computed from the adjusted daily series.

Is SUDEEPPHRM up or down today?

SUDEEPPHRM gained +2.75% in this session, trading between ₹1,300.00 and ₹1,357.40 against an open of ₹1,300.10.

Key takeaways

• Last price: ₹1,329.30 (+2.75%) — higher at the time of writing
• Day range: ₹1,300.00 – ₹1,357.40
• 52-week high: ₹1,296

About this report

Every figure on this page is read from a primary source at the timestamp shown — exchange boards for equities and indices, the exchange bid book for IPOs, published association rates for bullion, and consolidated exchange quotes for crypto — with no estimation or third-party commentary. Historical fields such as trailing returns and 52-week extremes are computed on the adjusted daily series so splits and bonuses do not create false gaps. A timestamp outside market hours reflects the last traded or last published value, not a live tick.

Related live pages

• Sudeep Pharma share price
• Sudeep Pharma quarterly results
• Stocks in news
• Top gainers
• Market dashboard

Sources

• NSE live board data via our exchange data feed
• Headline attribution links above point to the original publishers
• TrendRipperX Sudeep Pharma stock page

“This report is generated automatically from live exchange and official association data at the time stamped above. Prices move continuously — verify on the source before acting. Nothing here is investment advice.”